(R) -Zevaquenabant
Product Specifications
Target
Cannabinoid Receptor, NO Synthase
Related Pathways
Immunology/Inflammation, GPCR/G Protein
Bioactivity
(R) -Zevaquenabant ((R) -MRI-1867) is the enantiomer of Zevaquenabant. Zevaquenabant ((S) -MRI-1867) is a peripherally restricted, orally bioavailable dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS) . It is beneficial in improving chronic kidney disease (CKD) caused by obesity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Purified Anti-Human TCRγ/δ Antibody[B1]](https://cdn.genprice.uk/products/763/68dd14c4061270361e7d70c5/imageurl/e-ab-f11450p.webp)
BNC472190-100 1x 100 µL
Frataxin (Marker of Friedreich Ataxia) (FXN/2124), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 